ArticleCancer research2009

The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.

Tanguy Y Seiwert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.